JOURNAL OF INDEPENDENT MEDICAL RESEARCH

COLLABORATIVE PUBLISHING FOR THE 21stCENTURY


HOME         Peer Review These Papers         Papers Sent To PubMed         Peer Review Rules         Advisory Board         Contact Us

BBC Health Newsfeed
















































































































JOIMR brings together all the elements needed for successful medical publishing in this digital age - authors, with innovative information and concepts they need to communicate- peer reviewers, to ensure that an adequate standard of communication is maintained - and (status currently pending) the digital archive of Life Sciences literature maintained by PubMed Central.

Independent authors cannot call upon assistance from the technical writers and mentors which are available at larger academic and private institutions, and often have difficulty mastering the host of chores involved in publishing their research results. How to choose the best journal? how to nominate potential peer reviewers? how to effect the rewrites?

JOIMR provides a realtime forum where active and retired academics join with eminent researchers and industry veterans to pass along their knowledge and insights. When a manuscript has achieved the level of excellence required by PubMed Central, two qualified peer-reviewers recommend that it be promulgated, and it will (eventually) be communicated to the Life Sciences Archive.

No money changes hands - all participation in JOIMR is voluntary, from the Advisory Board right down to the folks coding the website. Each of us benefits from the public service that we are sharing. There are no perks, no glitz.

Register as an Author, a Peer-Reviewer, or a Visitor, and join us in "Collaborative Publishing for the 21st Century"

Archived Table of Contents

Volume 1, Number 1, May 2003

  1. Cantwell AR: The Eccrine Sweat Gland as a possible Focus of Infection with Acid-Fast Cell Wall Deficient Bacteria. JOIMR 2003;1(1):1
  2. Lee RE: SARS Coronavirus Appears to be an FcgammaR Agent, Causing an Hyperimmune Response via a CD13 pathway - Implication for Therapeutic Interventions. JOIMR 2003;1(1):2
  3. Lee RE: SARS E2-spike Protein Contains a Superantigen Between Residues 690 through 1050. JOIMR 2003;1(1):3

Volume 1, Number 2, June 2003

  1. Marshall TG: Brown, et al, ACCESS Study finds Bacterial Pathogens in Sarcoidosis Patients. JOIMR 2003;1(2):2
  2. Cantwell AR Jr: Cell Wall Deficient Bacteria in the Blood of Sarcoidosis Patients. JOIMR 2003;1(2):4
  3. Mangin MM: Antibiotics Do Help Chronic Sarcoidosis Patients. JOIMR 2003;1(2):1
  4. Marshall TG, Marshall FE: The Science Points to Angiotensin II and 1,25-dihydroxyvitamin D. JOIMR 2003;1(2):3

Volume 1, Number 3, July 2003

  1. Marshall TG, Marshall FE: Significance of Interferon-gamma in the Th1 Immune Reaction. JOIMR 2003;1(3):1
  2. Marshall TG, Marshall FE: Antibiotics in Sarcoidosis - Reflections on the First Year. JOIMR 2003;1(3):2

Volume 1, Number 4, August 2003

  1. Cantwell AR: Cell-Wall-Deficient Bacteria as a Possible Cause of Basal Cell Carcinoma JOIMR 2003;1(4):1

Volume 1, Number 5, September 2003

  1. Cantwell AR: Bacteria in Sarcoidosis and a Rationale for Antibiotic Therapy in this Disease. JOIMR 2003;1(5):1

Volume 1, Number 6, November 2003

  1. Cantwell AR: The Russell Body - The Forgotten Clue to the Bacterial Cause of Cancer. JOIMR 2003;1(6):1

Volume 2, Number 1, February 2004

  1. Mangin M: Observations of Jarisch-Herxheimer Reaction in Sarcoidosis Patients. JOIMR 2004;2(1):1
Volume 2, Number 2, April 2004

  1. Marshall TG, Fenter B, Marshall FE: Putative Antibacterial Mechanisms for Angiotensin II Receptor Blockers. JOIMR 2004;2(2):1
Volume 2, Number 3, May 2004

  1. Cantwell AR Jr.: Acid-Fast Bacteria In-Vivo in Prostate Cancer and the Connection between Prostate Cancer, Other Cancers, and the Kaposi’s Sarcoma Virus. JOIMR 2004;2(3):1

 

All webpages, layout and style are (C)Copyright 2003, JOIMR.ORG
Papers and Comments belong to the Persons who published them: (C)Copyright 2003, as attributed (read policy)
All rights are expressly reserved. Click to email webmaster. Examine our Privacy Policy